These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 20615064)

  • 1. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
    Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
    Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
    Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum.
    Fröbel J; Hartwig S; Passlack W; Eckel J; Haas R; Czibere A; Lehr S
    Arch Physiol Biochem; 2010; 116(4-5):174-80. PubMed ID: 20662595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
    Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-source decay causes artifacts in SELDI-TOF MS spectra.
    Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C
    J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
    Ndao M
    Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
    Solassol J; Marin P; Maudelonde T; Mangé A
    Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices.
    Poon TC
    Expert Rev Proteomics; 2007 Feb; 4(1):51-65. PubMed ID: 17288515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of endometriosis diagnostic model using plasma protein profiling].
    Liu HY; Zheng YH; Zhang JZ; Leng JH; Sun DW; Liu ZF; Zhu L; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):601-4. PubMed ID: 20003789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of colorectal cancer using proteomic patterns in serum].
    Zhao G; Gao CF; Song GY; Li DH; Wang XL
    Ai Zheng; 2004 Jun; 23(6):614-8. PubMed ID: 15191657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry.
    Zhou M; Prieto DA; Lucas DA; Chan KC; Issaq HJ; Veenstra TD; Conrads TP
    J Proteome Res; 2006 Sep; 5(9):2207-16. PubMed ID: 16944932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lucid Proteomics System for top-down biomarker research.
    Jourdain S; Bulman A; Dalmasso E
    Arch Physiol Biochem; 2010; 116(4-5):158-62. PubMed ID: 20507259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.